MYOFOL PLUS®: Comprehensive Nutritional Support From PCOS to Preconception

Women's reproductive health is influenced by a complex interaction of hormonal signaling, metabolic function, nutritional status and overall health.
For women living with polycystic ovary syndrome (PCOS), these factors can be particularly relevant. PCOS is associated with irregular menstrual cycles, ovulatory dysfunction and metabolic disturbances, including insulin resistance in many affected women.
When pregnancy becomes a goal, attention also turns toward preconception nutrition and ensuring adequate intake of essential vitamins and minerals.
MYOFOL PLUS® from Swiss-based CEDEM AG brings these considerations together in one nutritional formulation.
Combining 2,000 mg myo-inositol with folic acid, iron, iodine, selenium, coenzyme Q10 and Vitex extract, MYOFOL PLUS® is designed around the journey from PCOS-focused nutritional support to preconception readiness.
But how do its ingredients work, what does the scientific evidence actually support, and what should women know before using it?
This guide explores the formula, its nutritional rationale, the latest PCOS guidelines and important considerations for women planning pregnancy.
Understanding PCOS: Why Metabolic and Reproductive Health Are Connected
Polycystic ovary syndrome is one of the most common hormonal conditions affecting women of reproductive age.
According to the World Health Organization (WHO), PCOS affects an estimated 10–13% of women of reproductive age worldwide, with up to 70% of affected women remaining undiagnosed.
Possible features of PCOS include:
- Irregular or infrequent menstrual periods.
- Irregular or absent ovulation.
- Elevated androgen levels.
- Acne or excessive facial and body hair.
- Difficulty conceiving in some women.
- Metabolic disturbances, including insulin resistance.
Not every woman with PCOS experiences the same symptoms, and not every woman with PCOS has infertility.
PCOS is also not simply a disorder of the ovaries. Its metabolic features can influence long-term health, making individualized care particularly important.
Effective PCOS management may involve lifestyle interventions, monitoring of metabolic risk and medical treatment tailored to the individual's symptoms and reproductive goals.
For women planning pregnancy, healthcare professionals may also assess ovulation, nutritional status and other factors that influence fertility.
What Is MYOFOL PLUS®?
MYOFOL PLUS® is a once-daily food supplement developed by CEDEM AG as part of its women's health portfolio.
Its nutritional concept connects three areas of reproductive wellness:
- PCOS-focused nutrition: Myo-inositol participates in insulin-signaling pathways relevant to the metabolic features of PCOS.
- Reproductive physiology: Selected ingredients are involved in biological processes associated with menstrual-cycle physiology and cellular energy metabolism.
- Preconception nutritional readiness: Folic acid, iron, iodine and selenium provide nutrients with recognized physiological functions relevant to women of reproductive age.
The formula brings these seven ingredients together in a single daily sachet.
Importantly, MYOFOL PLUS® is a food supplement, not a medicine or a clinically established fertility treatment.
What's Inside MYOFOL PLUS®? The Complete Formula
According to CEDEM AG's updated August 2026 Product Knowledge, each daily sachet contains:
- Myo-Inositol: 2,000 mg.
- Folic Acid: 400 µg.
- Iron: 20 mg.
- Iodine: 150 µg.
- Selenium: 50 µg.
- Coenzyme Q10 (CoQ10): 5 mg.
- Vitex agnus-castus Dry Extract: 2 mg.
These ingredients have different biochemical and nutritional roles.
The formulation combines a compound studied in the metabolic context of PCOS with selected micronutrients relevant to nutritional preparation before pregnancy.
However, combining several ingredients does not automatically establish that the finished product improves ovulation, egg quality or pregnancy outcomes.
1. Myo-Inositol: The Metabolic Connection in PCOS
Myo-inositol is a naturally occurring compound involved in intracellular signaling.
It participates in pathways associated with insulin signaling, which has attracted scientific interest because insulin resistance is common among women with PCOS.
Insulin is a hormone that helps regulate blood glucose. In women with PCOS, impaired insulin sensitivity can contribute to metabolic disturbances and may interact with ovarian androgen production.
Myo-inositol has therefore been investigated for its potential effects on metabolic markers and reproductive outcomes in women with PCOS.
MYOFOL PLUS® provides 2,000 mg of myo-inositol per daily sachet.
What Does the 2023 International PCOS Guideline Say?
The 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome states that inositol may be considered according to individual preferences and values.
The guideline recognizes possible improvement in some metabolic measures, but emphasizes that clinical benefits remain limited, particularly for outcomes such as ovulation.
For women with PCOS-related infertility, the same guideline considers inositol an experimental fertility therapy because evidence for improvements in ovulation, pregnancy and live-birth outcomes remains uncertain.
Therefore, myo-inositol can be discussed as part of PCOS-focused nutritional support, but it should not be presented as a guaranteed method for restoring ovulation or achieving pregnancy.
2. Vitex Extract: Understanding Its Role in Reproductive Physiology
Vitex agnus-castus, also known as chaste tree berry, is a botanical ingredient studied in relation to menstrual-cycle symptoms and reproductive hormone signaling.
Some research suggests that certain Vitex preparations may influence dopaminergic signaling pathways involved in prolactin regulation.
Prolactin is a hormone with important reproductive functions. When prolactin levels are abnormally elevated, menstrual-cycle disturbances and ovulatory dysfunction may occur.
However, evidence from studies of individual Vitex extracts cannot automatically be applied to every product containing the botanical ingredient.
In particular, MYOFOL PLUS® contains 2 mg of Vitex dry extract per sachet, and no clinical effect on prolactin levels or menstrual-cycle regulation has been established for the finished formula.
Women with suspected elevated prolactin should seek medical evaluation to identify the underlying cause rather than relying on supplementation alone.
Important: The safety of Vitex during pregnancy is not established, and the US National Center for Complementary and Integrative Health advises that its use during pregnancy may be unsafe. Women planning pregnancy should discuss MYOFOL PLUS® with their healthcare professional before use and review continued use immediately if pregnancy is suspected or confirmed.
3. Coenzyme Q10: Cellular Energy and Reproductive Research
Coenzyme Q10, commonly called CoQ10, is a naturally occurring compound involved in mitochondrial energy metabolism.
Mitochondria are cellular structures responsible for many processes involved in energy production.
Oocyte maturation and early embryonic development are energy-dependent biological processes, which helps explain scientific interest in CoQ10 within reproductive research.
However, studies investigating CoQ10 and reproductive outcomes have used varying doses and study populations.
MYOFOL PLUS® provides 5 mg of CoQ10 per sachet.
The presence of CoQ10 provides a biochemical rationale for including the ingredient, but does not establish that this amount improves egg quality, ovarian reserve, fertilization rates or pregnancy outcomes.
4. Folic Acid: An Essential Part of Preconception Nutrition
Folic acid is one of the most important nutrients to consider before pregnancy.
It is a synthetic form of folate, a B vitamin involved in normal cell division and the formation of genetic material.
Folate also contributes to maternal tissue growth during pregnancy.
Most importantly, adequate folic acid intake before conception and during early pregnancy helps reduce the risk of neural tube defects, which affect the developing brain and spinal cord.
The US Centers for Disease Control and Prevention (CDC) recommends that women capable of becoming pregnant obtain 400 µg of folic acid daily.
MYOFOL PLUS® provides 400 µg of folic acid per daily sachet.
This amount aligns with the widely recommended daily intake for women capable of becoming pregnant.
However, some women may require individualized folic acid recommendations based on their medical history or other risk factors.
MYOFOL PLUS® should not be assumed to replace every element of a prenatal supplementation plan, particularly because the formula also contains a botanical extract whose pregnancy safety is uncertain.
5. Iron: Supporting Normal Red Blood Cell Formation
Iron is an essential mineral required for the normal formation of red blood cells and hemoglobin.
Hemoglobin allows red blood cells to transport oxygen throughout the body.
Iron also contributes to normal energy-yielding metabolism and the reduction of tiredness and fatigue.
Women of reproductive age may have increased attention to iron intake because menstrual blood loss contributes to iron requirements.
MYOFOL PLUS® contains 20 mg of iron per daily sachet.
Nevertheless, iron supplementation should be considered in the context of individual nutritional requirements and iron status.
Women with suspected iron deficiency may need clinical assessment, including appropriate laboratory tests.
Taking additional iron is not automatically beneficial for someone whose iron intake and stores are already adequate.
6. Iodine: Supporting Normal Thyroid Function
Iodine is essential for the normal production of thyroid hormones.
Thyroid hormones participate in multiple physiological processes, including normal metabolism.
Thyroid function also has an important relationship with reproductive health, and thyroid disorders may contribute to menstrual irregularities or difficulties conceiving.
MYOFOL PLUS® provides 150 µg of iodine per sachet.
Iodine contributes to normal thyroid-hormone production and thyroid function.
However, iodine supplementation does not treat PCOS itself, and women with thyroid disease should obtain individualized advice regarding appropriate iodine intake.
7. Selenium: Thyroid Function and Antioxidant Protection
Selenium is an essential trace mineral incorporated into proteins known as selenoproteins.
These proteins participate in processes associated with thyroid-hormone metabolism and protection against oxidative stress.
Selenium contributes to normal thyroid function and to protecting cells from oxidative stress.
MYOFOL PLUS® provides 50 µg selenium per daily sachet.
Although selenium is important for normal physiology, its inclusion in a formula does not establish that the product improves fertility, reduces PCOS-related inflammation or prevents miscarriage.
As with other micronutrients, both inadequate and excessive intake should be avoided.
MYOFOL PLUS® and the Journey From PCOS to Preconception
One of the defining features of MYOFOL PLUS® is its integrated nutritional concept.
Rather than focusing on a single nutrient, the formula connects three complementary areas of women's reproductive wellness.
Stage 1: PCOS-Focused Metabolic Nutrition
Myo-inositol participates in insulin-signaling pathways relevant to metabolic physiology.
This makes it a nutritionally relevant ingredient for discussion in the context of PCOS, although clinical results remain uncertain.
Stage 2: Reproductive Physiology
Vitex and CoQ10 have been investigated for their roles in reproductive hormone signaling and cellular energy metabolism.
However, their presence does not demonstrate that MYOFOL PLUS® normalizes menstrual cycles, reduces prolactin or improves egg quality.
Stage 3: Preconception Nutritional Readiness
Folic acid, iodine, iron and selenium provide nutrients involved in normal cellular, hematological and thyroid-related functions.
The 400 µg folic acid content is especially relevant to women capable of becoming pregnant.
Because preconception supplements may be continued into early pregnancy, the Vitex content makes professional review of MYOFOL PLUS® particularly important before and during attempts to conceive.
What Makes MYOFOL PLUS® Different From MYOFOL®?
Although their names are similar, MYOFOL® and MYOFOL PLUS® have distinct formulations.
MYOFOL® combines myo-inositol, white kidney bean extract and folate, with a focus on PCOS-related metabolic nutrition.
MYOFOL PLUS® combines 2,000 mg myo-inositol with folic acid, iron, iodine, selenium, CoQ10 and Vitex extract.
This creates a broader formula addressing multiple nutritional considerations across PCOS and the preconception period.
However, the word "PLUS" describes the formulation concept. It should not be interpreted as proof that MYOFOL PLUS® is clinically superior to MYOFOL®.
Explore the official MYOFOL® product information to understand the distinction between the two formulations.
Can MYOFOL PLUS® Improve Ovulation or Pregnancy Chances?
Clinical studies have investigated myo-inositol in women with PCOS, including outcomes related to menstrual cycles, ovulation and metabolic parameters.
Some individual studies have reported encouraging results, but findings are not sufficiently consistent to establish reliable improvements in fertility outcomes.
The 2023 International PCOS Guideline emphasizes that evidence for inositol in women with PCOS-related infertility remains uncertain.
Furthermore, studies investigating myo-inositol alone or combined with folic acid are not equivalent to clinical trials of the complete seven-ingredient MYOFOL PLUS® formulation.
Therefore, MYOFOL PLUS® should not be presented as clinically proven to restore ovulation, improve egg quality, increase pregnancy rates or prevent miscarriage.
Women with PCOS who are experiencing infertility should seek individualized reproductive evaluation and evidence-based care.
How to Use MYOFOL PLUS®
According to CEDEM AG's updated product documentation, the suggested use is:
- Empty the contents of one sachet into 150 mL of water.
- Mix until dissolved.
- Take one sachet daily, following the approved product instructions.
Do not exceed the suggested daily dose.
Because the formula contains Vitex, women planning pregnancy should discuss its suitability with their healthcare professional before beginning use.
Important Safety Information
MYOFOL PLUS® contains several active ingredients that may require individual consideration, particularly in women planning pregnancy.
- Pregnancy and breastfeeding: The product contains Vitex, for which safety during pregnancy and breastfeeding has not been established. Seek professional advice before use and review continued use promptly if pregnancy occurs.
- Iron intake: Each sachet provides 20 mg iron. Consider additional iron from other supplements and individual iron status.
- Thyroid conditions: The formula provides 150 µg iodine. Women with thyroid disorders should seek individualized advice.
- Phenylalanine: The product contains aspartame, which is a source of phenylalanine. This is relevant to individuals with phenylketonuria (PKU).
- Other supplements and medications: Review possible overlapping nutrient intake and interactions with a qualified healthcare professional.
- Daily dose: Do not exceed the recommended daily serving.
Store the product in a cool, dry place, protected from direct sunlight, and keep it out of reach of young children.
Food supplements should not replace a varied, balanced diet or appropriate medical care.
Frequently Asked Questions About MYOFOL PLUS®
1. What is MYOFOL PLUS® used for?
MYOFOL PLUS® is a food supplement designed for women seeking comprehensive nutritional support across PCOS-related metabolic considerations and preconception nutritional readiness.
2. How much myo-inositol does MYOFOL PLUS® contain?
Each daily sachet contains 2,000 mg of myo-inositol.
3. Can MYOFOL PLUS® help women with PCOS?
The formula contains myo-inositol, a compound studied for its potential metabolic effects in women with PCOS. However, clinical benefits remain uncertain, and the supplement should not replace individualized medical management.
4. Does MYOFOL PLUS® regulate menstrual cycles?
The ingredients have been studied in relation to metabolic and reproductive physiology, but reliable menstrual-cycle regulation has not been established for the finished formula.
5. Can MYOFOL PLUS® improve egg quality?
The formula contains CoQ10, a compound involved in mitochondrial energy metabolism. However, the available information does not establish that MYOFOL PLUS® improves egg quality or fertility outcomes.
6. Does MYOFOL PLUS® contain folic acid?
Yes. Each sachet contains 400 µg folic acid, matching the widely recommended daily amount for women capable of becoming pregnant.
7. Is MYOFOL PLUS® suitable for women planning pregnancy?
The product contains several nutrients relevant to preconception nutrition, but it also contains Vitex. Because the safety of Vitex during pregnancy is uncertain, women should consult their healthcare professional before use when planning to conceive.
8. Can MYOFOL PLUS® be used during pregnancy?
MYOFOL PLUS® should not be assumed suitable for use during pregnancy. Its Vitex content requires professional assessment, and continued use should be discussed promptly if pregnancy is suspected or confirmed.
9. Can MYOFOL PLUS® be used with other prenatal supplements?
Do not combine products without checking overlapping nutrients, particularly iron, folic acid, iodine and selenium. A healthcare professional can help determine an appropriate supplementation plan.
10. How should MYOFOL PLUS® be taken?
According to CEDEM's updated instructions, dissolve one sachet in 150 mL water and take once daily, subject to the approved product directions and individual suitability.
11. Is MYOFOL PLUS® a fertility medication?
No. MYOFOL PLUS® is a food supplement. It is not a fertility medicine and has not been established as a treatment for PCOS-related infertility.
12. How long does MYOFOL PLUS® take to work?
No clinically established timeframe for improvements in ovulation, menstrual regularity or pregnancy outcomes is available for the finished MYOFOL PLUS® formulation.
Final Verdict: A Broader Nutritional Approach to PCOS and Preconception
Women's reproductive health is influenced by metabolic, hormonal and nutritional factors that often overlap.
MYOFOL PLUS® reflects this complexity through a seven-ingredient formulation that brings together:
- 2,000 mg myo-inositol: Relevant to insulin-signaling biology studied in PCOS.
- 400 µg folic acid: An important part of preconception nutrition.
- Iron, iodine and selenium: Essential micronutrients supporting recognized physiological functions.
- CoQ10 and Vitex: Ingredients with biological and research interest in reproductive physiology, but without established fertility benefits for this finished formula.
The product's defining feature is its integrated nutritional positioning across PCOS-focused support and preparation for pregnancy.
However, nutritional support should not be confused with a clinically proven treatment for infertility or ovulatory dysfunction.
For women planning pregnancy, professional evaluation is especially important because the formulation includes Vitex, whose safety in pregnancy is uncertain.
MYOFOL PLUS® — Comprehensive Nutritional Support From PCOS to Preconception.
Explore CEDEM AG's official women's health portfolio for more information about MYOFOL PLUS® and other reproductive-health formulations.
For related reading, see Vitaminati's article on MYOFOL® and PCOS-focused nutrition. MYOFOL® is a separate product with a different formula.
Scientific References
- World Health Organization — Polycystic Ovary Syndrome. Updated January 2026.
- Teede HJ et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
- US Centers for Disease Control and Prevention — Folic Acid Safety, Interactions, and Health Outcomes. 2026.
- European Commission — Regulation (EU) No 432/2012: Authorized Health Claims for Vitamins and Minerals.
- National Center for Complementary and Integrative Health — Chasteberry: Usefulness and Safety.
- NIH Office of Dietary Supplements — Iron: Health Professional Fact Sheet.
- CEDEM AG — Official Women's Health Product Portfolio.
Medical disclaimer: This article provides educational information and does not replace professional medical advice. MYOFOL PLUS® is a food supplement, not a medicine. Women with PCOS, those receiving fertility treatment, and those planning or experiencing pregnancy should discuss supplement use with a qualified healthcare professional. Follow the current approved product labeling and do not exceed the recommended daily dose.